EU gives conditional approval to Kimberly‑Clark’s acquisition of Kenvue, requiring divestiture of European tampon brands
On 13 October 2026 the European Commission conditionally approved Kimberly‑Clark Corp’s purchase of Kenvue Inc. The approval hinges on Kimberly‑Clark selling its Kotex, Camelia and Record feminine‑hygiene brands in the European Economic Area to Turkish distributor Dilek Gıda Üretim. The deal clears the EU’s antitrust hurdle and moves the transaction toward completion.
Why it matters
The approval removes the principal regulatory obstacle, allowing the $40‑$48.7 billion merger to proceed, which could reshape the global personal‑care market. The required divestiture will keep competition in the European tampon market, preserving choice and price levels for consumers.
Key facts
- 1The European Commission granted conditional approval on 13 October 2026. marketscreener.com
- 2Kimberly‑Clark must divest its Kotex, Camelia and Record brands in the EEA. europeansting.com
- 3The divested assets will be sold to Turkish distributor Dilek Gıda Üretim. europeansting.com
- 4The transaction was notified to the Commission on 25 August 2026. europeansting.com
- 5Deal value reported as US$40 billion. marketscreener.com
- 6Deal value reported as US$48.7 billion. manilatimes.net
Open questions
- Deal value differs between sources: US$40 billion and US$48.7 billion.
Summary written by AlphAI AI Desk from 17 of 17 sources. Not investment advice. Figures are as stated by the linked sources.